Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AMB-05X |
Synonyms | |
Therapy Description |
AMB-05X is a monoclonal antibody targeting CSF1R, which potentially decreases tumor growth (J Clin Oncol 41, no. 16_suppl (June 01, 2023) TPS11585). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMB-05X | AMB05X|AMB 05X | CSF1R Antibody 5 | AMB-05X is a monoclonal antibody targeting CSF1R, which potentially decreases tumor growth (J Clin Oncol 41, no. 16_suppl (June 01, 2023) TPS11585). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06617858 | Phase II | AMB-05X | Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment | Not yet recruiting | USA | 0 |
NCT05349643 | Phase II | AMB-05X | A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT | Completed | USA | NLD | AUS | 0 |